Effect Of Topical Aerosolized Ropivacaine(0.75%)on Response To Extubation
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2020/07/026563
- Lead Sponsor
- DrNaresh Yerne
- Brief Summary
Ropivacaine has long-acting local anaesthetic and topical anaesthesia wit
The ropivacaine been has reported to significantly attenuate histamine-induced.topical of ropivacaine(nebulisation, infiltration, atomization) reported to significantly reduce extubation response in a hypertensive patient.
We will hypothesize that topical application inhibiting bit hemodynamic response cough reflex during extubation in operative patient under general anaesthesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- All
- Target Recruitment
- 90
ASA PS I or II schedule, for elective surgery under general anaesthesia requiring oral endotracheal intubation with the clinically normal airway.
- Severe cardiovascular, liver, and kidney disfunction; Allergies to amide local anesthetics; Patient with history of risk factor for perioperative aspiration of gastric ontents Difficult airway or history of maxillofacial and neck surgery; Chronic respiratory disease such as chronic obstructive pulmonary disease or asthma, recent respiratory tract infection, chronic cough, and current smoking.
- Patients with reoperation because of serious adverse events such as bleeding, Anesthesia time more than 4 h, and delayed extubation (more than 1 h without extubation) Prolong surgery (more than 3 hr) Transferd to the Intensive Care Unit (ICU) with the tube were eliminated.
- Medications invoving angiotensin converting enzyme inhibitor Refusal to participate in study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Hemodynamic response(Mean arterial pressure & HeartRate)toextubation; Will be assesed at extubation | After 2 min | After 5 min & Will be assesed at extubation | After 2 min | After 5 min 2.Cough occurring at extubation. Will be assesed at extubation | After 2 min | After 5 min
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
OTE, 1st floarGovernment Medical college and Hospital ;Nagpur
🇮🇳Nagpur, MAHARASHTRA, India
OTE, 1st floarGovernment Medical college and Hospital ;Nagpur🇮🇳Nagpur, MAHARASHTRA, IndiaNareshPrincipal investigator9404212734dr.naresh08@gmail.com